These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51. T-cell receptor excision circle levels after allogeneic stem cell transplantation are predictive of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome. Uzunel M; Sairafi D; Remberger M; Mattsson J; Uhlin M Stem Cells Dev; 2014 Jul; 23(14):1559-67. PubMed ID: 24617310 [TBL] [Abstract][Full Text] [Related]
52. [GVHD and GVL]. Teshima T Rinsho Ketsueki; 2009 Oct; 50(10):1407-19. PubMed ID: 19915349 [No Abstract] [Full Text] [Related]
53. Fatal GVHD demonstrating an involvement of respiratory muscle following donor leukocyte transfusion (DLT). Oshima Y; Takahashi S; Nagayama H; Nishiwaki K; Kobayashi Y; Tojo A; Okamoto S; Tani K; Ozawa K; Wakabayashi T; Sato N; Kobayashi S; Nakamura K; Ohya Y; Nukina N; Kanazawa I; Asano S Bone Marrow Transplant; 1997 Apr; 19(7):737-40. PubMed ID: 9156252 [TBL] [Abstract][Full Text] [Related]
54. Is there a role for autologous stem cell transplantation for patients with acute myelogenous leukemia? A retrospective analysis. Novitzky N; Thomas V; du Toit C; McDonald A Biol Blood Marrow Transplant; 2011 Jun; 17(6):875-84. PubMed ID: 20870030 [TBL] [Abstract][Full Text] [Related]
55. The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in patients above 50 years-a report from the EBMT acute leukemia working party. Rubio MT; Savani BN; Labopin M; Polge E; Niederwieser D; Ganser A; Schwerdtfeger R; Ehninger G; Finke J; Renate A; Craddock C; Kröger N; Hallek M; Jindra P; Mohty M; Nagler A J Hematol Oncol; 2016 Aug; 9(1):65. PubMed ID: 27488518 [TBL] [Abstract][Full Text] [Related]
56. Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes. Lee HC; Saliba RM; Rondon G; Chen J; Charafeddine Y; Medeiros LJ; Alatrash G; Andersson BS; Popat U; Kebriaei P; Ciurea S; Oran B; Shpall E; Champlin R Biol Blood Marrow Transplant; 2015 Nov; 21(11):1948-54. PubMed ID: 26183077 [TBL] [Abstract][Full Text] [Related]
57. Acute graft-versus-host-disease in acute myeloid leukemia: Clinicopathological correlation based on autopsy findings. Sharma P; Jandial A; Keisham A; Rohilla M; Varma N; Malhotra P; Radotra B Indian J Pathol Microbiol; 2021; 64(4):752-758. PubMed ID: 34673597 [TBL] [Abstract][Full Text] [Related]
58. Who is the best hematopoietic stem-cell donor for a male patient with acute leukemia? Ringdén O; Labopin M; Solders M; Beelen D; Arnold R; Ehninger G; Milpied N; Niederwieser D; Hamladji RM; Kyrcz-Krzemien S; Ganser A; Socié G; Stelljes M; Volin L; Craddock C; Mohty M; Transplantation; 2014 Sep; 98(5):569-77. PubMed ID: 24798307 [TBL] [Abstract][Full Text] [Related]
59. Graft versus host disease localized to striae distensae: An example of locus minoris resistentiae. Bishnoi A; Lad D; Ashraf R; Banerjee N; Saikia UN; Vinay K Indian J Dermatol Venereol Leprol; 2021 [SEASON]; 87(4):555-557. PubMed ID: 33871201 [No Abstract] [Full Text] [Related]
60. Polycythemia following allogeneic hematopoietic progenitor cell transplantation occurring during iron chelation therapy. Fedele R; Cuzzola M; Irrera G; Pontari A; D'Ascola DG; Oliva EN; Martino M Leuk Lymphoma; 2016; 57(4):969-72. PubMed ID: 26308385 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]